8 results
STEMI Equivalents on ECG
 • Conventional STEMI - Elevation of ST segment at (or 40-60 ms
on ECG • Conventional ... point • De Winter syndrome ... #Equivalents #ECG ... #EKG #diagnosis ... #differential #cardiology
Tumor Lysis Syndrome
An acute, life-threatening condition that appears within 7 days of starting cytotoxic therapies in
Tumor Lysis Syndrome ... with Ca only if EKG ... Walid Malki, MD, MS ... #TLS #oncology ... #management #UricAcid
Causes of ST Segment Elevation - Differential Diagnosis Framework

STEMI:
 • Upsloping convex STE: "Pardee's sign" +
Diagnosis Framework STEMI ... QRS complex Pulmonary ... STElevation #ST #STEMI ... differential #diagnosis #cardiology ... #ecg #ekg #electrocardiogram
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
ATRA treatment Pathophysiology ... Prednisone 5mg/kg ... Imaging: CXR- pulmonary ... APML #diagnosis #management ... #hematology #oncology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
complications from anesthesia ... indicated • EKG ... Obtain EKG if: ... one post op Cardiology ... medical and surgical management
Sarcoidosis - Diagnosis and Management Summary
Epidemiology
1) High incidence in Scandinavian countries (11-24 cases per 100,000 individuals
Diagnosis and Management ... survival is 93-95% Pathophysiology ... of diagnosis (e.g ... Pulmonary: dyspnea ... anterior/posterior MSK
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
bone marrow or stem ... Etiology: • Pathophysiology ... circulation: MCA ACA ... • EEG: With persistent ... #diagnosis #management
Hemophagocytic Lymphohistiocytosis (HLH)

High mortality without prompt recognition and management. HLH is a critical diagnostic consideration in
▪ Infections (e.g ... Pathophysiology ... pro-inflammatory cytokines (e.g ... Immunosuppression (e.g ... anti-IFN-γ antibodies (e.g